Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
21.73
-0.06 (-0.28%)
Jul 16, 2026, 12:28 PM EDT - Market open
Surrozen Market Cap
Surrozen has a market cap or net worth of $252.29 million as of July 16, 2026. Its market cap has increased by 250.14% in one year.
Market Cap
252.29M
Enterprise Value
152.86M
1-Year Change
250.14%
Ranking
Category
Stock Price
$21.73
ChartMarket Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $252.29M, an increase of 109.11%. That is a compound annual growth rate of 14.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 252.29M | 19.74% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 279.86M |
| MacroGenics | 279.68M |
| Greenwich LifeSciences | 273.90M |
| Niagen Bioscience | 268.57M |
| ALX Oncology Holdings | 266.43M |
| Cartesian Therapeutics | 263.26M |
| Conexeu Sciences | 262.50M |
| ProQR Therapeutics | 248.37M |